img

Global COVID-19 Vaccines & Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global COVID-19 Vaccines & Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

COVID-19 Vaccines & Therapeutics report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global COVID-19 Vaccines & Therapeutics market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Children and Adult are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for COVID-19 Vaccines & Therapeutics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, COVID-19 Vaccines & Therapeutics key companies include Pfizer, Moderna Therapeutics, AstraZeneca, Janssen, Novavax, Gilead Sciences and Eli Lilly and Company, etc. Pfizer, Moderna Therapeutics, AstraZeneca are top 3 players and held % share in total in 2023.
COVID-19 Vaccines & Therapeutics can be divided into COVID-19 Vaccines and COVID-19 Therapeutics, etc. COVID-19 Vaccines is the mainstream product in the market, accounting for % share globally in 2023.
COVID-19 Vaccines & Therapeutics is widely used in various fields, such as Children and Adult, etc. Children provides greatest supports to the COVID-19 Vaccines & Therapeutics industry development. In 2023, global % share of COVID-19 Vaccines & Therapeutics went into Children filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global COVID-19 Vaccines & Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Moderna Therapeutics
AstraZeneca
Janssen
Novavax
Gilead Sciences
Eli Lilly and Company
Segment by Type
COVID-19 Vaccines
COVID-19 Therapeutics

Segment by Application


Children
Adult
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the COVID-19 Vaccines & Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, COVID-19 Vaccines & Therapeutics introduction, etc. COVID-19 Vaccines & Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of COVID-19 Vaccines & Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.

Table of Content

1 Market Overview of COVID-19 Vaccines & Therapeutics
1.1 COVID-19 Vaccines & Therapeutics Market Overview
1.1.1 COVID-19 Vaccines & Therapeutics Product Scope
1.1.2 COVID-19 Vaccines & Therapeutics Market Status and Outlook
1.2 Global COVID-19 Vaccines & Therapeutics Market Size Overview by Region 2018 VS 2023 VS 2033
1.3 Global COVID-19 Vaccines & Therapeutics Market Size by Region (2018-2033)
1.4 Global COVID-19 Vaccines & Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global COVID-19 Vaccines & Therapeutics Market Size Forecast by Region (2024-2033)
1.6 Key Regions, COVID-19 Vaccines & Therapeutics Market Size (2018-2033)
1.6.1 North America COVID-19 Vaccines & Therapeutics Market Size (2018-2033)
1.6.2 Europe COVID-19 Vaccines & Therapeutics Market Size (2018-2033)
1.6.3 Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size (2018-2033)
1.6.4 Latin America COVID-19 Vaccines & Therapeutics Market Size (2018-2033)
1.6.5 Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size (2018-2033)
2 COVID-19 Vaccines & Therapeutics Market by Type
2.1 Introduction
2.1.1 COVID-19 Vaccines
2.1.2 COVID-19 Therapeutics
2.2 Global COVID-19 Vaccines & Therapeutics Market Size by Type: 2018 VS 2023 VS 2033
2.2.1 Global COVID-19 Vaccines & Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global COVID-19 Vaccines & Therapeutics Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America COVID-19 Vaccines & Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.2 Europe COVID-19 Vaccines & Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific COVID-19 Vaccines & Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America COVID-19 Vaccines & Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa COVID-19 Vaccines & Therapeutics Revenue Breakdown by Type (2018-2033)
3 COVID-19 Vaccines & Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Children
3.1.2 Adult
3.2 Global COVID-19 Vaccines & Therapeutics Market Size by Application: 2018 VS 2023 VS 2033
3.2.1 Global COVID-19 Vaccines & Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global COVID-19 Vaccines & Therapeutics Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America COVID-19 Vaccines & Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.2 Europe COVID-19 Vaccines & Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific COVID-19 Vaccines & Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America COVID-19 Vaccines & Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa COVID-19 Vaccines & Therapeutics Revenue Breakdown by Application (2018-2033)
4 COVID-19 Vaccines & Therapeutics Competition Analysis by Players
4.1 Global COVID-19 Vaccines & Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in COVID-19 Vaccines & Therapeutics as of 2023)
4.3 Date of Key Players Enter into COVID-19 Vaccines & Therapeutics Market
4.4 Global Top Players COVID-19 Vaccines & Therapeutics Headquarters and Area Served
4.5 Key Players COVID-19 Vaccines & Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 COVID-19 Vaccines & Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer COVID-19 Vaccines & Therapeutics Products, Services and Solutions
5.1.4 Pfizer COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Moderna Therapeutics
5.2.1 Moderna Therapeutics Profile
5.2.2 Moderna Therapeutics Main Business
5.2.3 Moderna Therapeutics COVID-19 Vaccines & Therapeutics Products, Services and Solutions
5.2.4 Moderna Therapeutics COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Moderna Therapeutics Recent Developments
5.3 AstraZeneca
5.3.1 AstraZeneca Profile
5.3.2 AstraZeneca Main Business
5.3.3 AstraZeneca COVID-19 Vaccines & Therapeutics Products, Services and Solutions
5.3.4 AstraZeneca COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Janssen Recent Developments
5.4 Janssen
5.4.1 Janssen Profile
5.4.2 Janssen Main Business
5.4.3 Janssen COVID-19 Vaccines & Therapeutics Products, Services and Solutions
5.4.4 Janssen COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Janssen Recent Developments
5.5 Novavax
5.5.1 Novavax Profile
5.5.2 Novavax Main Business
5.5.3 Novavax COVID-19 Vaccines & Therapeutics Products, Services and Solutions
5.5.4 Novavax COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Novavax Recent Developments
5.6 Gilead Sciences
5.6.1 Gilead Sciences Profile
5.6.2 Gilead Sciences Main Business
5.6.3 Gilead Sciences COVID-19 Vaccines & Therapeutics Products, Services and Solutions
5.6.4 Gilead Sciences COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Gilead Sciences Recent Developments
5.7 Eli Lilly and Company
5.7.1 Eli Lilly and Company Profile
5.7.2 Eli Lilly and Company Main Business
5.7.3 Eli Lilly and Company COVID-19 Vaccines & Therapeutics Products, Services and Solutions
5.7.4 Eli Lilly and Company COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Eli Lilly and Company Recent Developments
6 North America
6.1 North America COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 COVID-19 Vaccines & Therapeutics Market Dynamics
11.1 COVID-19 Vaccines & Therapeutics Industry Trends
11.2 COVID-19 Vaccines & Therapeutics Market Drivers
11.3 COVID-19 Vaccines & Therapeutics Market Challenges
11.4 COVID-19 Vaccines & Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market COVID-19 Vaccines & Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2023 VS 2033
Table 2. Global COVID-19 Vaccines & Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global COVID-19 Vaccines & Therapeutics Market Size Share by Region (2018-2023)
Table 4. Global COVID-19 Vaccines & Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global COVID-19 Vaccines & Therapeutics Forecasted Market Size Share by Region (2024-2033)
Table 6. Global COVID-19 Vaccines & Therapeutics Market Size (US$ Million) by Type: 2018 VS 2023 VS 2033
Table 7. Global COVID-19 Vaccines & Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global COVID-19 Vaccines & Therapeutics Revenue Market Share by Type (2018-2023)
Table 9. Global COVID-19 Vaccines & Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global COVID-19 Vaccines & Therapeutics Revenue Market Share by Type (2024-2033)
Table 11. North America COVID-19 Vaccines & Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America COVID-19 Vaccines & Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe COVID-19 Vaccines & Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe COVID-19 Vaccines & Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific COVID-19 Vaccines & Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific COVID-19 Vaccines & Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America COVID-19 Vaccines & Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America COVID-19 Vaccines & Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa COVID-19 Vaccines & Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa COVID-19 Vaccines & Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global COVID-19 Vaccines & Therapeutics Market Size (US$ Million) by Application: 2018 VS 2023 VS 2033
Table 22. Global COVID-19 Vaccines & Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global COVID-19 Vaccines & Therapeutics Revenue Market Share by Application (2018-2023)
Table 24. Global COVID-19 Vaccines & Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global COVID-19 Vaccines & Therapeutics Revenue Market Share by Application (2024-2033)
Table 26. North America COVID-19 Vaccines & Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America COVID-19 Vaccines & Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe COVID-19 Vaccines & Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe COVID-19 Vaccines & Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific COVID-19 Vaccines & Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific COVID-19 Vaccines & Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America COVID-19 Vaccines & Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America COVID-19 Vaccines & Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa COVID-19 Vaccines & Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa COVID-19 Vaccines & Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global COVID-19 Vaccines & Therapeutics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global COVID-19 Vaccines & Therapeutics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in COVID-19 Vaccines & Therapeutics as of 2023)
Table 39. Date of Key Players Enter into COVID-19 Vaccines & Therapeutics Market
Table 40. Global COVID-19 Vaccines & Therapeutics Key Players Headquarters and Area Served
Table 41. COVID-19 Vaccines & Therapeutics Product Solution and Service
Table 42. Global COVID-19 Vaccines & Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Pfizer Basic Information List
Table 45. Pfizer Description and Business Overview
Table 46. Pfizer COVID-19 Vaccines & Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of Pfizer (2018-2023)
Table 48. Pfizer Recent Developments
Table 49. Moderna Therapeutics Basic Information List
Table 50. Moderna Therapeutics Description and Business Overview
Table 51. Moderna Therapeutics COVID-19 Vaccines & Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of Moderna Therapeutics (2018-2023)
Table 53. Moderna Therapeutics Recent Developments
Table 54. AstraZeneca Basic Information List
Table 55. AstraZeneca Description and Business Overview
Table 56. AstraZeneca COVID-19 Vaccines & Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of AstraZeneca (2018-2023)
Table 58. AstraZeneca Recent Developments
Table 59. Janssen Basic Information List
Table 60. Janssen Description and Business Overview
Table 61. Janssen COVID-19 Vaccines & Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of Janssen (2018-2023)
Table 63. Janssen Recent Developments
Table 64. Novavax Basic Information List
Table 65. Novavax Description and Business Overview
Table 66. Novavax COVID-19 Vaccines & Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of Novavax (2018-2023)
Table 68. Novavax Recent Developments
Table 69. Gilead Sciences Basic Information List
Table 70. Gilead Sciences Description and Business Overview
Table 71. Gilead Sciences COVID-19 Vaccines & Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of Gilead Sciences (2018-2023)
Table 73. Gilead Sciences Recent Developments
Table 74. Eli Lilly and Company Basic Information List
Table 75. Eli Lilly and Company Description and Business Overview
Table 76. Eli Lilly and Company COVID-19 Vaccines & Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of Eli Lilly and Company (2018-2023)
Table 78. Eli Lilly and Company Recent Developments
Table 79. North America COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 80. North America COVID-19 Vaccines & Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 81. Europe COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 82. Europe COVID-19 Vaccines & Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 83. Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 84. Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 85. Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 86. Asia-Pacific COVID-19 Vaccines & Therapeutics Market Share by Region (2018-2023)
Table 87. Asia-Pacific COVID-19 Vaccines & Therapeutics Market Share by Region (2024-2033)
Table 88. Latin America COVID-19 Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 89. Latin America COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 90. Latin America COVID-19 Vaccines & Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 91. Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 92. Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 93. Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 94. COVID-19 Vaccines & Therapeutics Market Trends
Table 95. COVID-19 Vaccines & Therapeutics Market Drivers
Table 96. COVID-19 Vaccines & Therapeutics Market Challenges
Table 97. COVID-19 Vaccines & Therapeutics Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Vaccines & Therapeutics Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global COVID-19 Vaccines & Therapeutics Market Size (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global COVID-19 Vaccines & Therapeutics Market Share by Regions: 2023 VS 2033
Figure 4. Global COVID-19 Vaccines & Therapeutics Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America COVID-19 Vaccines & Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe COVID-19 Vaccines & Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America COVID-19 Vaccines & Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of COVID-19 Vaccines
Figure 11. Global COVID-19 Vaccines Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of COVID-19 Therapeutics
Figure 13. Global COVID-19 Therapeutics Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global COVID-19 Vaccines & Therapeutics Market Size Share by Type: 2023 & 2033
Figure 15. North America COVID-19 Vaccines & Therapeutics Revenue Market Share by Type (2018-2033)
Figure 16. Europe COVID-19 Vaccines & Therapeutics Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific COVID-19 Vaccines & Therapeutics Revenue Market Share by Type (2018-2033)
Figure 18. Latin America COVID-19 Vaccines & Therapeutics Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa COVID-19 Vaccines & Therapeutics Revenue Market Share by Type (2018-2033)
Figure 20. Children Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Adult Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Global COVID-19 Vaccines & Therapeutics Market Size Share by Application: 2023 & 2033
Figure 23. North America COVID-19 Vaccines & Therapeutics Revenue Market Share by Application (2018-2033)
Figure 24. Europe COVID-19 Vaccines & Therapeutics Revenue Market Share by Application (2018-2033)
Figure 25. Asia-Pacific COVID-19 Vaccines & Therapeutics Revenue Market Share by Application (2018-2033)
Figure 26. Latin America COVID-19 Vaccines & Therapeutics Revenue Market Share by Application (2018-2033)
Figure 27. Middle East and Africa COVID-19 Vaccines & Therapeutics Revenue Market Share by Application (2018-2033)
Figure 28. COVID-19 Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2023
Figure 29. Global Top 5 and Top 10 Players COVID-19 Vaccines & Therapeutics Market Share in 2023
Figure 30. North America COVID-19 Vaccines & Therapeutics Market Share by Country (2018-2033)
Figure 31. United States COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 32. Canada COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 33. Germany COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 34. France COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 35. U.K. COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 36. Italy COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 37. Russia COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 38. Nordic Countries COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific COVID-19 Vaccines & Therapeutics Market Share by Region (2018-2033)
Figure 40. China COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 41. Japan COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 42. South Korea COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 43. Southeast Asia COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 44. India COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 45. Australia COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 46. Latin America COVID-19 Vaccines & Therapeutics Market Share by Country (2018-2033)
Figure 47. Mexico COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 48. Brazil COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa COVID-19 Vaccines & Therapeutics Market Share by Country (2018-2033)
Figure 50. Turkey COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 51. Saudi Arabia COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 52. UAE COVID-19 Vaccines & Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries